Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.000
-0.090 (-2.91%)
May 30, 2025, 4:00 PM - Market closed

Eledon Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
8.520.554.6156.4184.83114.2
Upgrade
Short-Term Investments
116.39119.6346.49---
Upgrade
Cash & Short-Term Investments
124.88140.1851.156.4184.83114.2
Upgrade
Cash Growth
191.36%174.31%-9.41%-33.51%-25.71%1199.00%
Upgrade
Other Receivables
-----0.11
Upgrade
Receivables
-----0.11
Upgrade
Prepaid Expenses
2.842.824.943.083.481.29
Upgrade
Other Current Assets
-0.730.090.030.030.04
Upgrade
Total Current Assets
127.72143.7356.1359.5288.35115.63
Upgrade
Property, Plant & Equipment
0.850.930.370.740.770.14
Upgrade
Goodwill
----48.6548.65
Upgrade
Other Intangible Assets
32.3932.3932.3932.3932.3932.39
Upgrade
Other Long-Term Assets
0.350.360.190.150.40.38
Upgrade
Total Assets
161.31177.4189.0792.79170.55197.19
Upgrade
Accounts Payable
2.95.830.972.21.811.37
Upgrade
Accrued Expenses
5.965.432.553.912.220.97
Upgrade
Current Portion of Leases
0.330.310.380.360.370.14
Upgrade
Total Current Liabilities
9.1911.583.96.484.42.48
Upgrade
Long-Term Leases
0.560.64-0.380.4-
Upgrade
Long-Term Deferred Tax Liabilities
2.182.181.751.751.754.11
Upgrade
Other Long-Term Liabilities
34.8144.8776.21---
Upgrade
Total Liabilities
46.7359.2781.868.616.556.59
Upgrade
Common Stock
0.060.060.020.010.010.02
Upgrade
Additional Paid-In Capital
476.62473.64326.59287.03278.88270.97
Upgrade
Retained Earnings
-362.08-355.59-319.4-202.87-114.9-80.39
Upgrade
Comprehensive Income & Other
-0.020.03----
Upgrade
Total Common Equity
114.58118.147.2184.18164190.6
Upgrade
Shareholders' Equity
114.58118.147.2184.18164190.6
Upgrade
Total Liabilities & Equity
161.31177.4189.0792.79170.55197.19
Upgrade
Total Debt
0.880.950.380.750.770.14
Upgrade
Net Cash (Debt)
124139.2250.7255.6684.06114.05
Upgrade
Net Cash Growth
191.23%174.50%-8.88%-33.78%-26.29%1247.01%
Upgrade
Net Cash Per Share
2.062.872.063.905.6778.58
Upgrade
Filing Date Shares Outstanding
59.8859.8824.8113.7814.3114.31
Upgrade
Total Common Shares Outstanding
59.8859.7924.2113.7814.3115.16
Upgrade
Working Capital
118.53132.1552.2353.0483.95113.15
Upgrade
Book Value Per Share
1.911.980.306.1111.4612.57
Upgrade
Tangible Book Value
82.1985.75-25.1851.882.96109.56
Upgrade
Tangible Book Value Per Share
1.371.43-1.043.765.807.23
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q